Home › Funds › DAYMARK WEALTH PARTNERS, LLC › JNJ

DAYMARK WEALTH PARTNERS, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

DAYMARK WEALTH PARTNERS, LLC reported holding 282,563 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$74.8M, representing 1.70% of its reported portfolio and ranking #9 among its reported holdings. DAYMARK WEALTH PARTNERS, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)282.56K sh
Reported value held$74.81M
Portfolio Weight1.70%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How DAYMARK WEALTH PARTNERS, LLC's JNJ position evolved

DAYMARK WEALTH PARTNERS, LLC first disclosed a stake in JNJ in Q3 2023 at 289,921 shares (US$26.7M). The position peaked in Q3 2026 at 282,563 shares, worth US$74.8M. Across 13 filings, DAYMARK WEALTH PARTNERS, LLC increased the stake 8 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 282,563 shares valued at US$74.8M — an increase of 16,153 shares quarter over quarter.. Notable position changes include a 36% trim in Q1 2025 (shares fell 6% over the following quarter), a 26% increase in Q2 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 289.92K $26.74M New
Q4 2023 295.02K $27.71M Add
Q1 2024 298.17K $28.46M Add
Q2 2024 304.20K $27.19M Add
Q3 2024 300.75K $29.57M Reduce
Q4 2024 310.03K $27.75M Add
Q1 2025 197.43K $32.74M Reduce
Q2 2025 199.06K $30.41M Add
Q3 2025 212.72K $39.44M Add
Q4 2025 212.10K $43.89M Hold
Q1 2026 211.78K $51.77M Hold
Q2 2026 266.41K $67.66M Add
Q3 2026 282.56K $74.81M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has DAYMARK WEALTH PARTNERS, LLC held JNJ?

DAYMARK WEALTH PARTNERS, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is DAYMARK WEALTH PARTNERS, LLC's current position in JNJ?

As of Q3 2026, DAYMARK WEALTH PARTNERS, LLC holds 282.56K shares of JNJ (JOHNSON & JOHNSON), valued at $74.81M, representing 1.70% of its reported portfolio and ranking #9.

Has DAYMARK WEALTH PARTNERS, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), DAYMARK WEALTH PARTNERS, LLC increased its position in JNJ. The position peaked in Q3 2026 at 282.56K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.